AZN vs NGVT
ASTRAZENECA PLC vs Ingevity Corp — Side-by-Side Stock Comparison
AZN
ASTRAZENECA PLC
8.4
Strong Buy
$200.99
NGVT
Ingevity Corp
7.6
Strong Buy
$72.30
AZN vs NGVT: Which is the Better Investment?
ASTRAZENECA PLC (AZN) scores 8.4/10 while Ingevity Corp (NGVT) scores 7.6/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | AZN | NGVT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 8.4/10▲ | 7.6/10 |
| Rating | Strong Buy▲ | Strong Buy |
| Price | $200.99 | $72.30 |
| P/E Ratio | 30.4 | — |
| ROE | 21.9% | 30.0%▲ |
| Market Cap | $312B | $3B |
| Fair Value | $192.63 | — |
| Dividend Yield | 1.6% | — |
| Sector Rank | #3 of 1127▲ | #31 of 1127 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Strong▲ | Attractive |
| Graham | Caution | Neutral▲ |
| Lynch | Neutral | Attractive▲ |
| Greenblatt | Neutral | Strong▲ |
AZN vs NGVT: Which Stock Scores Higher?
ASTRAZENECA PLC (AZN) and Ingevity Corp (NGVT) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to NGVT's 7.6/10 (Strong Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer